During pregnancy, human placenta-associated microRNAs (miRNAs) derived from the miRNA cluster in human chromosome 19 are expressed in villous trophoblasts and secreted into maternal circulation via exosomes; however, little is known about whether circulating placenta-associated miRNAs are transferred into maternal immune cells via exosomes, and modulate expression of target genes in the recipient cells. We employed an in vitro model of trophoblast-immune cell communication using BeWo cells (a human trophoblast cell line) and Jurkat cells (a human leukemic T-cell line) and investigated whether BeWo exosomal placenta-associated miRNAs can suppress expression of target genes in the recipient Jurkat cells. Using this system, we identified PRKG1 as a target gene of placenta-associated miRNA miR-517a-3p. Moreover, we demonstrated that BeWo exosomal miR-517a-3p was internalized into Jurkat cells and subsequently suppressed the expression of PRKG1 in recipient Jurkat cells. Furthermore, using peripheral blood natural killer (NK) cells in vivo, we confirmed that circulating miR-517a-3p was delivered into maternal NK cells as it was into Jurkat cells in vitro. Placenta-associated miR-517a-3p was incorporated into maternal NK cells in the third trimester, and it was rapidly cleared after delivery. Expression levels of miR-517a-3p and its target mRNA PRKG1 were inversely correlated in NK cells before and after delivery. These in vitro and in vivo results suggest that exosome-mediated transfer of placenta-associated miRNAs and subsequent modulation of their target genes occur in maternal NK cells. The present study provides novel insight into our understanding of placentamaternal communication.
INTRODUCTION
Exosomes are nanovesicles (30-100 nm) of multivesicular body origin that can be released from the cell surface by exocytosis [1] . Most cell types are believed to be able to secrete exosomes [2] , which can reach bodily fluids, such as plasma [3] , urine [4] , semen [5] , milk [6] , and saliva [7] . To date, it is well known that exosomes contain RNAs, lipids, and many kinds of proteins, which are all thought to transfer from the cell of origin to adjacent or distant cells and influence biological functions of the recipient cells [8, 9] . There has been a growing interest in the role of exosomal microRNAs (miRNAs) in cellcell communication since Valadi et al. [10] demonstrated that miRNAs exist in exosomes. MicroRNAs are small noncoding RNAs approximately 22 nucleotides in length that play a pivotal role in posttranscriptional gene regulation by repressing target mRNA translation by base pairing to the 3 0 -untranslated region (3 0 -UTR) [11, 12] . Recent studies have suggested that exosomes have the capacity to shuttle genetic information from cell to cell by transferring miRNAs [13] .
MicroRNAs within the human imprinted chromosome 19 miRNA cluster (C19MC), a primate-specific miRNA cluster encompassing 46 miRNAs in the human genome, are expressed exclusively in the placenta (i.e., placenta-associated miRNAs) [14] [15] [16] . Although C19MC-associated miRNAs are not detected in other normal adult tissues, they were also identified in some cancer cells [17] . Recent studies have shown that C19MC-associated miRNAs that are packaged within trophoblast-derived exosomes confer viral resistance in recipient cells by the induction of autophagy [18, 19] . However, the biological functions of C19MC-associated miRNAs for the placenta and pregnancy are still not fully understood. We reported previously that placenta-associated miRNAs are expressed in human villous trophoblasts and are secreted into the maternal circulation via exosomes [20] . Exosomal miRNAs are generally considered to be stable in the circulation [21] . This has raised the possibility that exosomal placentaassociated miRNAs may be detected in the circulation during pregnancy [22, 23] and may serve as novel predictive markers [24] . However, there is little information on how exosomal placenta-associated miRNAs participate in cell-cell communication and possibly contribute to the maintenance of pregnancy.
Based on the aforementioned findings of exosomal miRNAs, we hypothesized that circulating placenta-associated miRNAs might be transferred via exosomes from placental trophoblasts into maternal immune cells and repress expression of target genes in the recipient cells. To test our hypothesis, we initially attempted to search target genes of placenta-associated miRNAs in human peripheral blood immune cells using a DNA microarray analysis. However, this in vivo evaluation proved difficult because these immune cells already contain various miRNAs derived not only from placental cells but also many other cell types [25] . In this study, to avoid the complexity of microarray experiments using circulating cells, we have developed an in vitro model system of trophoblastimmune cell communication using BeWo cells (a human trophoblast cell line) [26] and Jurkat cells (a human leukemic T-cell line) [27] . Using this system, we identified PRKG1 as a target gene of the placenta-associated miRNA miR-517a-3p, via a combination of DNA microarray and in silico analyses. We showed that exosomal miR-517a-3p can transfer from BeWo cells into Jurkat cells and modulate the target gene within the recipient cells. Furthermore, we evaluated the uptake of circulating miR-517a-3p into immune cells using peripheral blood samples from pregnant women.
MATERIALS AND METHODS

Cell Culture
Jurkat and BeWo cells were purchased from the RIKEN Bioresource Center. JEG3 cells were obtained from the European Collection of Cell Cultures. Jurkat cells were maintained in exosome-free RPMI 1640 medium (Gibco) supplemented with 10% fetal bovine serum (FBS; Japan Bioserum; 378C, 5% CO 2 ); BeWo cells were cultured in exosome-free Ham F-12 medium (Invitrogen) supplemented with 15% FBS (378C, 5% CO 2 ); JEG-3 was cultured in exosome-free E-MEM (Wako) supplemented with 10% FBS, 1% nonessential amino acids, and 1 mM pyruvate (378C, 5% CO 2 ). Exosomefree medium was prepared by ultracentrifugation at 100 000 3 g for 12 h at 48C according to the method of Thery et al. [28] .
Isolation of Peripheral Blood Immune Cells from Pregnant Women
Samples of peripheral blood were obtained from full-term pregnant women who gave informed consent (n ¼ 24; gestational age, 36-38 wk). Protocols were approved by the ethics committees of Nippon Medical School and Jichi Medical University. Postdelivery maternal blood samples were also collected 4 days after delivery. Women with significant comorbid medical conditions or concomitant medications that would substantially impact immunologic function were excluded from the study. Peripheral blood mononuclear cells (MNCs) were isolated from heparinized venous blood using Lymphoprep (Axis-Shield PoC AS). Briefly, after the blood was centrifuged at 1490 3 g for 15 min at 48C, the pellet was resuspended in PBS containing 1% bovine serum albumin (buffer A). The MNCs were isolated from the suspension according to the manufacturer's instructions, and then were resuspended in buffer A. Natural killer (NK) cells and regulatory T (Treg) cells were isolated from the MNCs using Dynabeads Untouched NK-cell and Dynabeads Regulatory CD4 þ CD25 þ T-cell kits (Invitrogen), respectively, according to the manufacturer's instructions. Total RNA from the cells was extracted as described below.
Exosome Isolation from Culture Supernatants
Exosomes were isolated from the supernatant of trophoblast cell lines according to the method of Thery et al. [28] . Briefly, culture supernatants were harvested and sequentially centrifuged at 48C at 300 3 g for 10 min, 2000 3 g for 10 min, and 10 000 3 g for 30 min to eliminate cells, dead cells, and cell debris. The supernatants were filtered through a 0.22-lm filter and then ultracentrifuged at 100 000 3 g for 70 min at 48C to pellet exosomes. Exosomal pellets were washed twice in PBS and then resuspended in 200 ll of PBS. The protein content of purified exosomes was determined using a BCA protein assay kit (Pierce).
Exosomes were also prepared from culture supernatants of BeWo cells transfected with Pre-miR-517a (mature miR-517a-3p mimic; Applied Biosystems), Pre-miR-1, or Pre-miR Negative Control no. 1 (Pre-miR-NC) to investigate the effect of these miRNAs in the recipient Jurkat cells. BeWo cells were transfected with Pre-miR reagents (30 nM) using Lipofectamine 2000 (Invitrogen) for 4 h. After 48 h of transfection, culture supernatants were collected for exosome isolation. Exosomes from Pre-miR-517a-transfected, Pre-miR-1-transfected, and Pre-miR-NC-transfected BeWo cells were designated miR-517a-3p-loaded, miR-1-loaded, and miR-NC-loaded exosomes, respectively; exosomes from nontransfected cells were designated wild-type exosomes.
RNA Extraction and Purification
Total RNA within whole cells was extracted using RNAiso reagent (Takara), followed by cleanup with RNeasy Mini Kits (Qiagen), according to the manufacturer's instructions. Total RNA within exosomes was extracted using mirVana miRNA Isolation Kits (Applied Biosystems) according to the manufacturer's instructions.
Real-Time PCR Analysis
Real-time PCR for miRNAs was carried out using TaqMan MicroRNA Assays (Applied Biosystems) in a 7300 Real-Time PCR System (Applied Biosystems) or a 7900 FAST Real-Time PCR System (Applied Biosystems). Briefly, total RNA was reverse transcribed with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). The RT products were subsequently subjected to a real-time PCR reaction using TaqMan 2X Universal PCR Master Mix (Applied Biosystems). To quantify mRNA levels, SYBR Premix Ex Taq (Takara Bio) was applied. Total RNA was reverse transcribed with PrimeScript RT reagent Kit (Takara). To quantify mRNA levels, SYBR Premix Ex Taq was applied. To normalize expression levels of miRNAs and mRNAs, SNORD44 and GAPDH were used as endogenous internal controls, respectively. Primers for miR-512-3p (assay ID 001823), miR-517a-3p (assay ID 002402), miR-518b (assay ID 001156), and miR-1 (assay ID 002222) were from Applied Biosystems. Primers for mRNAs (Eurofins Genomics) were as follows: ALDH1B1: forward, CCTGGCTGCGGCTGTGTTCA; reverse, ATGGCGTGTGGCAGGTGACG; ANP32E: forward, CCCCGGAGGAGGTGACAGAGT; reverse, AGCCGGGC CAGCGAACTTAG; DHFR: forward, CTGCATCGTCGCTGTGTCCCA; reverse, ATTCCTGAGCGGTGGCCAGG; FAT2: forward, TCCAGAGTGAG GAAGAGGTA; reverse, TGTGGAGAATTGGGGTATAG; IGSF5: forward, CTGGACCCGGCTCCCGGATA; reverse, GAAGGTCGCTGGGCTCCGGA; PRKG1: forward, AGGAGCTGAGGCAGCGGGAT; reverse, CAAGGTGC TCGCGCTCTGCT; TWF1: forward, GGAGGACAAACAACCATGCTA; reverse, GGGAAGATTGTGACAGCAAGT; and RSPO3: forward, TCGGCAGC CAAAACGCCTCC; reverse, TGCACAGCCTCCTTGGCAGC.
Western Blot Analysis
Proteins derived from BeWo cells or Jurkat cells were obtained using M-PER Mammalian Protein Extraction Reagent (Thermo Fisher Scientific) containing Halt Protease Inhibitor Cocktail (Thermo Fisher Scientific). Proteins were separated on 10% SDS-PAGE gels and were transferred onto Sequi-blot PVDF membranes (Bio-Rad). Blots were incubated at 48C overnight with primary antibodies followed by incubation with horseradish peroxidaseconjugated secondary antibodies. Antibodies used in Western blotting were as follows: anti-CD63 monoclonal antibody (mAb; Sanquin), anti-CD81 polyclonal antibody (pAb; Santa Cruz Biotechnology), anti-TSG101 pAb (Sigma-Aldrich), anti-ACTB mAb (Sigma-Aldrich), anti-PRKG1 mAb (Cell Signaling Technologies), and horseradish peroxidase-conjugated secondary antibodies (Pierce). Signals were detected using Immobilon reagent (Millipore) and visualized using an LAS-4000 Lumino image analyzer (Fujifilm).
Immunoelectron Microscopy Analysis
For immunogold labeling of CD63, an mAb (H5C6; provided by Developmental Studies Hybridoma Bank, Department of Biological Sciences, University of Iowa) was employed. Exosomes were fixed with 4% paraformaldehyde (Merck) in PBS, and 20 ll of the suspension was placed on 300-mesh nickel grids (Electron Microscopy Sciences) coated with Formvar (Nisshin EM), for 20 min at 228C. After blocking with 5% normal goat serum (Sigma-Aldrich) in PBS, grids bearing exosomes were incubated with anti-CD63 for 30 min at 378C. The grids were then incubated with goat anti-mouse immunoglobulin G (IgG) pAb conjugated to 10-nm colloidal gold particles (Jackson Immunoresearch), for 30 min at 378C. Immunolabeled exosomes on grids were postfixed with 2% glutaraldehyde in PBS for 30 min at 228C, and then negatively stained with 4% uranyl acetate according to the method of Sakai et al. [29] . Control grids received the same treatment except that the primary antibody was replaced with nonimmune isotype-matched IgG (MOPC-21; Sigma-Aldrich). Samples were observed under a Hitachi H-7650 electron microscope system (Hitachi High-Technologies) operated at 80 kV.
Morphometric analysis of isolated vesicles in electron micrographs was performed. The size of isolated vesicles was measured, and the number of the vesicles labeled with and without colloidal gold particles indicating CD63 was KAMBE ET AL.
counted on the micrographs printed at the same magnification (150 0003). A total of 221 vesicles were analyzed.
Microarray Analysis in miR-517a-3p-Overexpressing Jurkat Cells
Jurkat cells were transfected with Pre-miR-517a or Pre-miR NC at a final concentration of 40 nM using Lipofectamine 2000. Pre-miR-transfected cells were harvested 48 h after transfection and total RNA was extracted as described above. The integrity of RNA for microarray analysis was determined using an Agilent 2100 Bioanalyzer (Agilent Technologies); samples with RNA integrity number greater than 7 were used. Of the total RNA obtained, 100 ng was used in a labeling reaction using a Low-Input QuickAmp Labeling Kit, One-Color (Agilent Technologies), and the quality and yield of labeled cRNA were evaluated on an Agilent 2100 Bioanalyzer. Gene expression profiling was conducted using an Agilent microarray (Human GE 4344 K, v2). The resulting signals were normalized to the 75th percentile signal intensity, and processed data were filtered using a 2-fold change threshold with GeneSpring GX software (v. 11.5; Agilent Technologies). The mRNA array data are publicly available (Gene Expression Omnibus accession no. GSE50814; http://www. ncbi.nlm.nih.gov/geo/; accessed September 12, 2013).
MicroRNA Target Prediction
We focused on downregulated mRNAs as potential direct targets of miR517a-3p in the above DNA microarray analysis. The online prediction software MicroCosm Targets version 5 (http://www.ebi.ac.uk/enright-srv/microcosm/ htdocs/targets/v5/; accessed October 1, 2011) was used to search for predicted target genes of miR-517a-3p.
Luciferase Assay
To construct a reporter plasmid, we first cloned the 3 0 -UTR of the human PRKG1 gene (GenBank accession no. NM_006258) into the pMIR-REPORT vector, in which firefly luciferase expression reports miRNA activity (Applied Biosystems). Genomic DNA from Jurkat cells was isolated using the FastPure DNA Kit (Takara). The 3 0 -UTR of the PRKG1 mRNA was then amplified from isolated genomic DNA using the following primers: 5 0 -CAGGACTAGTTG-TATTTCTCTTACCTGCTTCTGCCT-3 0 (SpeI site underlined) and 5 0 -GGCAAAGCTTGTTACTTATGACAGCTAATAATAGTCAACTGGC-3 0 (HindIII site underlined). After sequence verification by cloning into a pCRBlunt II-TOPO vector, the PRKG1 3 0 -UTR was cloned into pMIR-REPORT via the SpeI and HindIII restriction sites. This final construct was designated pMIR-PRKG1. To construct a reporter plasmid with a mutated miR-517a-3p recognition site of PRKG1 3 0 -UTR (see Fig. 3D ), an inverse PCR method was used. The primers used for the inverse PCR were PRKG1 3 0 -UTR mut forward, 5 0 -ACAGAagactgaaaaattagtacgtaaATTTGTTTGTTTTTTTTGATAAATTGG CATG-3 0 ; and PRKG1 3 0 -UTR mut reverse, 5 0 -ACAAATttacgtactaattttt cagtctTCTGTGAAAACTCATATATACCTACTATGAGAGGTCTC-3 0 (complementary sequence shown in lowercase), and were designed to introduce the mutation. The PCR amplification was carried out using the previously cloned vector pCR-Blunt II-TOPO containing the PRKG1 3 0 -UTR. Plasmid DNA was digested by DpnI. The final construct was confirmed by sequencing using an ABI PRISM 3130 Genetic Analyzer (Applied Biosystems). Amplified DNA was transformed into Escherichia coli. After sequence verification, the mutated 3 0 -UTR sequence was cloned into pMIR-REPORT via SpeI and HindIII restriction sites. The final construct was designated pMIR-PRKG1mt.
Jurkat cells were transfected with pMIR-PRKG1, pMIR-PRKG1mt, or pMIR-cont (empty vector pMiR-REPORT), and the control vector pRL-TK (Renilla luciferase expression plasmid), together with Pre-miR-517a or PremiR-NC (30 nM), using Lipofectamine 2000 in 24-well plates. Twenty-four hours after transfection, luciferase assays were performed using the Dual Luciferase Reporter Assay System (Promega). Firefly luciferase activity was normalized to Renilla luciferase activity.
Transfer of BeWo Exosomes into Recipient Cells
Jurkat cells were incubated with exosomes isolated from trophoblast cell lines (50 lg/ml) for 24-48 h, and real-time PCR was performed for quantification of miRNA and mRNA as described above. For luciferase assay, Jurkat cells were transfected with pMIR-PRKG1or pMIR-cont, and the control vector pRL-TK. After 24 h of transfection, cells were incubated with BeWo exosomes for another 24 h, and then luciferase assays were performed. Some cells were incubated with BeWo exosomes for 24 h, washed twice with PBS, and then treated with TrypLE Express Enzyme solution (recombinant trypsinlike serine protease [13] in Dulbecco PBS/1 mM ethylene diamine tetraacetic acid [EDTA]; Gibco) for 10 min at 378C. The expression levels of miR-517a-3p were assayed by real-time PCR.
Isolated peripheral blood immune cells were incubated with BeWo exosomes (50 lg/ml) in exosome-free RPMI 1640 medium supplemented with 10% FBS for 24 h, and the expression levels of miR-517a-3p were assayed by real-time PCR.
Statistical Analysis
We conducted all analyses using the SPSS statistical software package (Windows version 20; IBM-SPSS). The significance of between-group differences was assessed using Student t-test, ANOVA followed by Tukey test, or Kruskal-Wallis test, and P values ,0.05 were considered to indicate statistical significance.
RESULTS
Characterization of Exosomes Derived from BeWo Cells
We first investigated whether BeWo cells could release exosomes into the extracellular space. Because exosomes are known to express CD63, CD81, and TSG101 [3] , we examined expression of these molecules in the exosomal fraction isolated from BeWo cell culture medium. As shown in Figure 1A , Western blotting detected all of these molecules in the exosomal fraction, indicating that BeWo cells secrete exosomes into the culture medium. We also confirmed the secretion of exosomes from BeWo cells by immunoelectron microscopy (Fig. 1B) . Morphometric analysis of isolated vesicles showed that approximately 80% of the vesicles were positive for CD63. Most of the vesicles were in the 26-to 125-nm range (diameter [mean 6 SD], 85 6 33 nm; Fig. 1C ). Moreover, we determined whether the placenta-associated miRNA miR-517a-3p exists in exosomes derived from BeWo cells by real-time PCR (Fig. 1D) . As expected, miR-517a-3p was identified in exosomes secreted from BeWo cells but was not detectable in Jurkat cells.
In Vitro Model of Trophoblast-Immune Cell Communication
To investigate the possibility of functional miRNA transfer from placenta trophoblasts to maternal peripheral blood immune cells via exosomes, we employed an in vitro model system using BeWo and Jurkat cells (Fig. 2A) . To confirm whether this system serves as an in vitro model of cell-to-cell communication via exosomes, we first examined transfer of placenta-associated miRNAs to Jurkat cells. Because human placenta expresses placenta-associated miRNAs, such as miR-512-3p and miR-517a-3p, which are secreted into maternal circulation via exosomes [20, 30] , we evaluated the presence of these miRNAs in Jurkat cells after incubation with exosomes released from trophoblast cell lines (BeWo and JEG3 cells) by real-time PCR. When Jurkat cells were incubated with BeWo or JEG3 exosomes for 24 h, miR-512-3p and miR-517a-3p were detected in the cells (Fig. 2B) . In contrast, these miRNAs were not detectable in Jurkat cells treated without exosomes (vehicle). It is likely that miRNAs were transferred into Jurkat cells via trophoblast cell line exosomes.
Target Identification of Placenta-Associated miRNA miR517a-3p in Jurkat Cells
As shown in Figure 2A , a BeWo exosomal miRNA would be expected to bind to a partially complementary sequence (seed sequence) in the 3 0 -UTR of its target mRNA and suppress translation in recipient Jurkat cells. We next investigated whether BeWo-derived placenta-associated miRNAs function as posttranscriptional gene regulators within EXOSOMAL COMMUNICATION OF PLACENTA MICRORNA Jurkat cells after exosome-mediated miRNA transfer. For this purpose, we initially identified candidate target mRNAs of the placenta-associated miRNAs using DNA microarray analysis. In this examination, we focused on miR-517a-3p as a representative exosomal placenta-associated miRNA, because this miRNA was detected at high levels in the plasma of pregnant women [20] and in isolated human trophoblast cells [30, 31] . Transfection of Jurkat cells with Pre-miR-517a significantly downregulated 123 genes (Supplemental Table  S1 , available online at www.biolreprod.org). Among the 123 genes identified, we searched for potential direct targets of miR-517a-3p using the online software MicroCosm Targets. Seven genes, ALDH1B1, ANP32E, DHFR, FAT2, IGSF5, PRKG1, and RSPO3, had at least one potential miR-517a-3p-binding site in their 3 0 -UTRs. To confirm downregulated expression of these seven genes, we performed real-time PCR. Among the seven mRNAs selected, PRKG1 was significantly downregulated in miR517a-3p-overexpressing Jurkat cells (Fig. 3A) , whereas expression of ALDH1B1, ANP32E, DHFR, FAT2, and RSPO3 was not significantly altered (data not shown). IGSF5 expression was undetectable (data not shown). As shown in Figure 3B , PRKG1 protein expression was markedly decreased in Pre-miR-517a-transfected cells compared with control cells. Therefore, we focused on PRKG1 for miR-517a-3p target validation.
We used a luciferase assay to determine whether PRKG1 is a direct target of miR-517a-3p. Overexpression of miR-517a-3p significantly decreased luciferase activity in Jurkat cells cotransfected with pMIR-PRKG1 (49% reduction compared with the negative control), but not significantly in cells cotransfected with pMIR-PRKG1mt (Fig. 3C ), a reporter plasmid in which the putative miR-517a-3p recognition site in the PRKG1 3 0 -UTR is mutated (Fig. 3D) . Taken together, these results suggest that PRKG1 is a target of miR-517a-3p in Jurkat cells.
Effect of BeWo Exosomal miR-517a-3p on PRKG1 Expression in Jurkat Cells
We further investigated whether BeWo exosomal miR517a-3p can modulate PRKG1 mRNA expression within recipient Jurkat cells. In this examination, we also used miR517a-3p-loaded exosomes collected from culture supernatants of BeWo cells transfected with Pre-miR-517a to enhance the effect of this miRNA in the recipient Jurkat cells because we could not generate C19MC mir-517a gene-knockout BeWo cells. As shown in Figure 4A , levels of miR-517a-3p were greatly increased in the exosome fraction of cell culture supernatants from Pre-miR-517a-transfected BeWo cells (more than 30-fold greater than that from nontransfected cells).
We quantified exosomal miR-517a-3p in Jurkat cells incubated with BeWo exosomes. miR-517a-3p was not 
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detected in Jurkat cells incubated without BeWo cell exosomes (vehicle), and miR-517a-3p levels were increased significantly in Jurkat cells treated with BeWo wild-type exosomes (Fig.  4B) . Moreover, when Jurkat cells were treated with BeWo miR-517a-3p-loaded exosomes, markedly greater levels of miR-517a-3p levels were transferred to recipient cells compared with treatment with wild-type exosomes (Fig. 4B) . We then investigated whether transferred exosomal miR-517a-3p represses endogenous PRKG1 expression in Jurkat cells. As expected, the expression levels of PRKG1 were slightly but significantly decreased in Jurkat cells incubated with wild-type exosomes (42% reduction) compared with vehicle-treated cells (Fig. 4C) . Further, downregulation of PRKG1 expression was significantly enhanced by treatment with miR-517a-3p-loaded exosomes (70% reduction) compared with vehicle-treated cells (Fig. 4C ). In addition, we measured exosomal miR-517a-3p in Jurkat cells incubated with BeWo miR-NC-loaded exosomes. No differences were found in the expression levels of miR517a-3p and PRKG1 between cells treated with miR-NCloaded exosomes and wild-type exosomes (data not shown).
We also confirmed that exosomal miR-517a-3p bound to the 3 0 -UTR of PRKG1 in recipient cells by luciferase assay. In pMIR-PRKG1-transfected Jurkat cells, BeWo wild-type exosomes significantly reduced luciferase activity (31% reduction) compared with pMIR-cont-transfected cells; downregulation of PRKG1 expression was enhanced by incubation with miR517a-3p-loaded exosomes (51% reduction) compared with pMIR-cont-transfected cells (Fig. 4D) . Furthermore, we investigated whether remaining cell surface-bound BeWo exosomes affect the expression levels of miR-517a-3p that was transferred to Jurkat cells. Jurkat cells were incubated with BeWo exosomes for 24 h, followed by TrypLE digestion (recombinant trypsin-like serine protease-EDTA). These were no differences in the miRNA expression levels between miR517a-3p recipient cells treated with and without TrypLE (Fig.  4E) . These results show that BeWo exosomal miRNA miR517a-3p internalized into Jurkat cells and subsequently repressed expression of the target gene PRKG1 therein.
We used miR-517a-3p-loaded exosomes for assessment of the effect of BeWo exosomal miR-517a-3p on PRKG1 in Jurkat cells. An miR-1 transfection and TWF1 detection system [32] was also employed to demonstrate that BeWo exosomal miRNAs can transfer to Jurkat cells and suppress target genes in the recipient cells. TWF1 mRNA is a validated target of miR-1, and the repression occurs at the mRNA level [33] . When BeWo miR-1-loaded exosomes were incubated with Jurkat cells, miR-1 was significantly detected in the recipient cells (Fig. 4F) . In contrast, miR-1 was undetectable in Jurkat cells treated with BeWo miR-NC-loaded exosomes (Fig, 4F) . As expected, the miR-1 recipent cells displayed a 55% knockdown of TWF1 mRNA compared with the miR-NC recipient cells (Fig. 4G ). The inverse relationship between miR-1 expression and the expression level of TWF1 mRNA provided additional data supporting that BeWo exosomal miRNAs can transfer to Jurkat cells and suppress target genes in the recipient cells. As mentioned above, placenta-associated miRNAs are detectable in the maternal circulation during pregnancy [20, 22, 23] . We next investigated whether these miRNAs in the maternal circulation are delivered into immune cells in peripheral blood as they are into Jurkat cells in vitro. For this purpose, we examined whether miR-517a-3p and miR-518b are present in immune cells isolated from maternal peripheral blood using real-time PCR. These placenta-associated miRNAs   FIG. 3 . Validation of PRKG1 as a miR-517a-3p target. A) Real-time PCR analysis of candidate miR-517a-3p target mRNA PRKG1 in Jurkat cells. Jurkat cells were transfected with Pre-miR-517a (517a) or Pre-miR-NC (NC), each 40 nM, and cultured for 48 h. Expression of PRKG1 was examined by real-time PCR. Data were normalized to GAPDH. Expression in cells treated with Pre-miR-NC was defined as 1. B) Western blots for PRKG1 in Jurkat cells transfected with Pre-miR517a or Pre-miR-NC (30 lg of total protein per lane). ACTB served as the internal control. Analysis of band intensity is presented as the relative ratio of PRKG1 to ACTB. The relative ratio of PRKG1 in cells treated with Pre-miR-NC was defined as 1. C) PRKG1 3 0 -UTR luciferase reporter assay. Reporter vector (pMIR-RPKG1 or pMIR-PRKG1mt) and Pre-miRNA (Pre-miR-517a or Pre-miR-NC [each 30 nM]) were cotransfected into Jurkat cells. Renilla luciferase vector pRL-TK was used as the internal control. Luciferase expression levels in cells cotransfected with pMIR-RPKG1 and Pre-miR-NC were defined as 1. D) Sequences of mature miR517a-3p, its putative target site in the 3 0 -UTR of PRKG1, and the mutation introduced into the miR-517a-3p recognition site of PRKG1 3 0 -UTR in the reporter plasmid. Data are means 6 SD of the results from three independent experiments. Student t-test (A and B) or Tukey test (C); *P , 0.05, **P , 0.01. "
FIG. 4. Transfer of miRNAs into Jurkat cells via BeWo exosomes. A)
Real-time PCR analysis of miR-517a-3p in BeWo wild-type exosomes (Wt-Ex) and miR-517a-3p-loaded exosomes (517a-Ex); expression in Wt-Ex was defined as 1. B) Detection of transferred miR-517a-3p in Jurkat cells cultured with BeWo exosomes. Jurkat cells were treated with vehicle, Wt-Ex, or 517a-Ex (each 50 lg/ml) for 48 h at 378C. Expression was analyzed by real-time PCR; data were normalized to SNORD44. Expression in Jurkat cells incubated with Wt-Ex was defined as 1. C) PRKG1 silencing by exosomal miR-517a-3p KAMBE ET AL. t-test (A, D-G) or Tukey test (B and C); **P , 0.01, ***P , 0.001.
EXOSOMAL COMMUNICATION OF PLACENTA MICRORNA
were detected in maternal MNCs before delivery (data not shown). Furthermore, we evaluated the expression of miR517a-3p and miR-518b in maternal NK and Treg cells (Fig. 5 , A and B) because these cell types play important roles in the maintenance of pregnancy [34, 35] . In NK cells, abundant miR517a-3p and miR-518b were detected before delivery; the levels of these miRNAs were significantly reduced at 4 days after delivery (Fig. 5, A and B) . In contrast, negligible levels of miR-517a-3p and miR-518b were detected in Treg cells even before delivery; no differences were found in miRNA levels between before and after delivery (Fig. 5, A and B) . In addition, miR-517a-3p and miR-518b were undetectable in NK and Treg cells from women with no history of pregnancy (Fig.  5, A and B) . We also investigated whether expression of PRKG1 mRNA in maternal NK and Treg cells changes after delivery. As shown in Figure 5C , expression of PRKG1 in maternal NK cells was significantly upregulated at 4 days after delivery. In maternal Treg cells, the change of PRKG1 levels was not significant (Fig. 5C ). Expression levels of transferred exosomal miR-517a-3p and its target PRKG1mRNA were inversely correlated and were dependent on pregnancy status, supporting the above-mentioned hypothesis that placental exosomal miRNAs modulate the expression of target genes in maternal immune cells.
To determine whether the uptake of placenta-associated miRNA miR-517a-3p into maternal immune cells is dependent on exosomes, we employed an in vitro cell-cell communication model, this time employing male NK and Treg cells instead of Jurkat cells. A significant increase in miR-517a-3p levels was detected in NK cells treated with BeWo wild-type exosomes compared with NK cells incubated without BeWo exosomes (Fig. 5D) , providing direct evidence that BeWo exosomes can deliver miR-517a-3p to NK cells. Unlike maternal Treg cells, exosome-mediated uptake of miR-517a-3p into Treg cells was observed in this in vitro model system; however, lower levels of miR-517a-3p were transferred into Treg cells than into NK cells (Fig. 5D) .
DISCUSSION
Until recently, intercellular communication had been thought to be take place only through cell-to-cell adhesion conduits or secreted signals, such as hormones, cytokines, and neurotransmitters. In addition to these, exosomal RNAs and proteins have been shown to play an important role in intercellular communication [10, 36, 37] . During pregnancy, exosomes are involved in cell-to-cell communication between the placenta and peripheral blood immune cells. For example, Taylor et al. [38] , Sabapatha et al. [39] , and Atay et al. [40] reported that placenta-derived exosomes exist in the maternal circulation and suppress T-cell signaling components. However, these functional studies measured placental exosomeassociated proteins, such as Fas ligand, MHC class I chainrelated proteins, and fibronectin. Although it is likely that exosomal C19MC miRNAs contribute to placental-maternal communication, few studies have examined whether exosomal placenta-associated miRNAs modulate the expression of their targets in recipient maternal immune cells.
In the present study, we investigated the possible involvement of exosomal placenta-associated miRNAs in communication between trophoblasts and immune cells using in vitro and in vivo approaches. First, we employed an in vitro model system. We attempted to search target genes of placentaassociated miRNA miR-517a-3p using an in vitro trophoblast (BeWo)-immune cell (Jurkat) model system because little has been reported on experimentally validated targets of miR-517a-3p. In the present study, we identified PRKG1 as a target gene of the placenta-associated miR-517a-3p (Fig. 3) and demonstrated that BeWo exosomal miR-517a-3p was transferable to Jurkat cells and suppressed the expression of PRKG1 mRNA within the recipient cells (Fig. 4) . Next, using maternal peripheral blood cells as an in vivo approach, we confirmed that miR-517a-3p in the maternal circulation was delivered into NK cells in peripheral blood as it was into Jurkat cells in vitro. We revealed a negative correlation between the expression levels of transferred exosomal miR-517a-3p and its target mRNA PRKG1 in maternal NK cells before and after delivery (Fig. 5, A and C) . In addition, we presented that miR-517a-3p was transferred into NK cells via BeWo exosomes (Fig. 5D) . These in vivo and in vitro results suggest that exosomemediated transfer of placenta-associated miRNAs and subsequent modulation of their target genes occur in maternal NK cells during pregnancy.
PRKG1 is a serine/threonine kinase that acts as a key mediator of the nitric oxide (NO)/cGMP signaling pathway [41, 42] . PRKG1 plays a central role in regulating cardiovascular and neuronal functions in addition to relaxing smooth muscle tone, preventing platelet aggregation, and modulating cell growth. In mammals, PRKG1 is strongly expressed in smooth muscle, platelets, cerebellum, hippocampus, dorsal root ganglia, the end plates of neuromuscular junctions, and kidney [43, 44] . In terms of PRKG1 in immune cells, Fischer et al. [45] reported that the NO/cGMP/PRKG1 signaling system negatively regulates T-cell activation and proliferation. Although the biological function of PRKG1 in NK cells is unclear, our present data together with previous findings suggest that miR-517a-3p is involved in regulating the activation and proliferation of maternal immune cells by inhibiting NO/cGMP/PRKG1 signaling.
Placenta-associated miRNAs were reduced in maternal NK cells rapidly after delivery (Fig. 5, A and B) . What mechanism is involved in this rapid clearance of placenta-associated miRNAs in NK cells? There are some possible explanations for rapid turnover dynamics of placenta-associated miRNAs in NK cells. First, it is possible that the supply of placenta exosomes, including placenta-associated miRNAs, is stopped after a termination of pregnancy. Another explanation may be that rapid degradation of miRNAs occurs in NK cells. Because placenta-associated miRNA levels in maternal plasma decreased dramatically after delivery [20] , it seems likely that the halt of the supply of placenta exosomes affects rapid clearance of placenta-associated miRNAs rather than miRNA turnover in NK cells.
Natural killer cells are well known to play important roles in the maintenance of human pregnancy [34] . Although we identified one target gene of miR-517a-3p using the in vitro model system used in this study, we could not find other target genes that are associated with immune tolerance in pregnancy. A single miRNA targets multiple mRNAs, and a single mRNA is regulated by multiple miRNAs. This relationship between miRNAs and target genes makes it difficult to study the functional roles of miRNAs. Recently, Olarerin-George et al. [46] have shown miR-517a-3p to be a potent activator of nuclear factor-kappa B signaling. Nuclear factor-kappa B plays pivotal roles in immune response [47] . Further identification of targets of these miRNAs and studies of their functions are warranted to comprehensively understand the precise mechanisms by which placental exosomal miRNA-mediated modulation of maternal NK cells contributes to fetomaternal immunotolerance during pregnancy.
The specificity of the exosome-mediated communication between trophoblasts and immune cells remains to be KAMBE ET AL. elucidated. Exosomes differ in their cellular origin [48] . Thus, cell type-specific molecules on the cell surface of exosomes may promote specific delivery to target cells. In addition to the exosome-mediated communication between BeWo and Jurkat cells, we investigated the possible involvement of miR-517a-3p in exosome-mediated communication between BeWo and human umbilical vein endothelial cells. Although BeWo exosomal miR-517a-3p was transferable to human umbilical vein endothelial cells as well as Jurkat cells, it suppressed the expression of different target genes within the nonimmune recipient cells (our unpublished data). The mechanism by which placental exosomes preferentially target and modulate specific cells has not yet been determined. In the present study, cell lines were primarily employed. Differential ultracentrifugation employed in this study could not separate relatively large vesicles (e.g., 150-to 200-nm vesicles). As reported by Bobrie et al. [49] , improved techniques will be needed to accurately purify the different populations of extracellular vesicles. To further characterize trophoblast-derived exosomes (e.g., the cell surface properties and target cell-specific delivery) and reveal the functional roles of exosome-mediated placenta-associated miRNAs in maternal NK cells, future work should be performed using a combination of primary immune cells and exosomes isolated from primary human trophoblasts.
FIG. 5.
Transferred placenta-associated miRNAs in the peripheral blood immune cells of pregnant women. A and B) Quantification of transferred placenta-associated miRNAs in maternal immune cells. Transferred miR-517a-3p (A) and miR-518b (B) were measured by real-time PCR in NK and Treg cells isolated from maternal peripheral blood samples at 1 day before delivery (Pre) and 4 days after delivery (Post). NK, n ¼ 15; Treg, n ¼ 9. The NK and Treg cells were also obtained from nonpregnant women with no history of pregnancy (NP; n ¼ 5). Data were normalized to SNORD44. Expression in NK before delivery was defined as 1. Lines inside boxes denote medians; boxes represent the interquartile range; and whiskers extend to the most extreme values within 1.5 times the interquartile range. C) Differential expression of PRKG1 mRNA in maternal peripheral blood immune cells before and after delivery. PRKG1 expression in maternal NK cells (n ¼ 5) and Treg cells (n ¼ 6) obtained from pregnant women both 1 day before delivery (Pre) and 4 days after delivery (Post) was investigated by real-time PCR. Data were normalized to GAPDH. Expression in NK before delivery was defined as 1. D) In vitro transfer of BeWo miR-517a-3p into male NK and Treg cells. After incubation of each cell type in the presence (Wt-Ex) or absence (Vehicle) of BeWo wildtype exosomes (50 lg/ml) for 48 h at 378C, levels of transferred miR-517a-3p were analyzed by real-time PCR (n ¼ 5 each). Data were normalized to SNORD44. Expression in Treg cells incubated with exosomes was defined as 1. Data are means 6 SD. Kruskal-Wallis test; *P , 0.05, **P , 0.01.
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